Skip to main content
Caplight Logo









Evecxia Therapeutics

Evecxia Therapeutics

Private
Durham, North CarolinaHealthcare & Life Scienceshttps://evecxia.com/

Last Round

VC Round

Sep 22, 2025

Total Funding Raised

$6.5M

Company Overview

Evecxia Therapeutics is a biotechnology company that develops proprietary drug delivery technologies to amplify serotonin synthesis for the treatment of neuropsychiatric disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Mental Health

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticaltreatment-resistant depressionserotonin modulationclinical-stage biotechadjunctive therapysleep disorders5-hydroxytryptophan5-HTPdrug developmentneuropsychiatrymental health therapeuticsclinical trialsCNS drug discoverypharma pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Evecxia Therapeutics Comparables

Compare Evecxia Therapeutics with similar companies based on industry and business-model similarity.

Evecxia Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Clexio Biosciences
80%
Autobahn Therapeutics
77%
EmbarkNeuro
74%

Evecxia Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 22, 2025
VC RoundAug 27, 2021
Series AJun 30, 2020

Key People

Founding team and executive leadership

Jacob Pade Ramsøe Jacobsen

Chief Executive Officer

Executive Team

Evecxia Therapeutics Investors

Notable investors and investment history

Evecxia Therapeutics investors
InvestorRounds
Collage Venture PartnersVC Round
Transhuman CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2025

    Monthly visitors grew 103% MoM.

  • May 2, 2025

    Monthly visitors increased 33% MoM.

Evecxia Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Evecxia Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Evecxia Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range6
Year Founded2013
Last FundingSep 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?